These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20170771)

  • 1. Measuring success in atrial fibrillation: Groping the elephant.
    Zivin A
    Heart Rhythm; 2010 May; 7(5):602-3. PubMed ID: 20170771
    [No Abstract]   [Full Text] [Related]  

  • 2. Sinus rhythm is associated with fewer heart failure symptoms: insights from the AFFIRM trial.
    Guglin M; Chen R; Curtis AB
    Heart Rhythm; 2010 May; 7(5):596-601. PubMed ID: 20159046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate vs rhythm control in atrial fibrillation: can observational data trump randomized trial results?
    Dewland TA; Marcus GM
    Arch Intern Med; 2012 Jul; 172(13):983-4. PubMed ID: 22665022
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil eliminates the hierarchical nature of activation frequencies from the pulmonary veins to the atria during paroxysmal atrial fibrillation.
    Kushiyama Y; Osaka T; Yokoyama E; Hasebe H; Kuroda Y; Kamiya K; Kodama I
    Heart Rhythm; 2010 May; 7(5):577-83. PubMed ID: 20206318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhythm control of atrial fibrillation in heart failure.
    Heijman J; Voigt N; Abu-Taha IH; Dobrev D
    Heart Fail Clin; 2013 Oct; 9(4):407-15, vii-viii. PubMed ID: 24054474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation: rate versus rhythm control.
    Amani F; Smith ES
    J Ark Med Soc; 2005 Oct; 102(4):110-2. PubMed ID: 16265929
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atrial fibrillation: where is the border between pure antiarrhythmic and non-antiarrhythmic medicines?].
    Moiseev SV
    Kardiologiia; 2012; 52(2):85-90. PubMed ID: 22799018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.
    Badheka AO; Marzouka GR; Rathod AD; Patel NJ; Myerburg RJ; Mitrani RD
    Am J Cardiol; 2013 Jun; 111(12):1759-63. PubMed ID: 23540545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.
    Hanley CM; Robinson VM; Kowey PR
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002479. PubMed ID: 26936819
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictive value of the heart rate reserve in patients with permanent atrial fibrillation treated according to a strict rate-control strategy.
    De Schryver N; Scavée C; Marchandise S; Pasquet A; de Meester C; le Polain de Waroux JB
    Europace; 2014 Aug; 16(8):1125-30. PubMed ID: 24599938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate versus rhythm control in atrial fibrillation: no one-size-fits-all.
    McClanahan AL; Curtis AB
    Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):891-3. PubMed ID: 20602548
    [No Abstract]   [Full Text] [Related]  

  • 13. Is rate control better than rhythm control for atrial fibrillation in older high-risk patients?
    Saseen JJ
    J Fam Pract; 2003 Mar; 52(3):192, 194. PubMed ID: 12620170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhythm control and increased risk of noncardiovascular death in the Atrial Fibrillation Follow-up Investigation of Rhythm Management trial.
    Boriani G; Biffi M; Mattioli S
    Circulation; 2004 Sep; 110(11):e307-8; author reply e307-8. PubMed ID: 15364827
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphology and pathophysiology of target anatomical sites for ablation procedures in patients with atrial fibrillation. Part I: atrial structures (atrial myocardium and coronary sinus).
    Corradi D; Callegari S; Gelsomino S; Lorusso R; Macchi E
    Int J Cardiol; 2013 Oct; 168(3):1758-68. PubMed ID: 23806836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method of multisite atrial pacing, incorporating Bachmann's bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation.
    Lewicka-Nowak E; Kutarski A; Dabrowska-Kugacka A; Rucinski P; Zagozdzon P; Raczak G
    Europace; 2007 Sep; 9(9):805-11. PubMed ID: 17670780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing?
    Nattel S; Dobrev D
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):409-11. PubMed ID: 26371951
    [No Abstract]   [Full Text] [Related]  

  • 18. Selection of drugs in pursuit of a rhythm control strategy.
    Kowey PR; Stoenescu ML
    Prog Cardiovasc Dis; 2005; 48(2):139-45. PubMed ID: 16253653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old habits die hard: the quest for correct(ed) QT interval measurements.
    Husser D; Hindricks G
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):914-5. PubMed ID: 20626523
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrophysiological study of the anti-arrhythmic activity of delagil and its modifying effect in patients with paroxysmal atrial fibrillation].
    Danilenko AM; Gimrikh EO; Chekhov AM; Marochkin AS; Gushchin IV
    Kardiologiia; 1988 Feb; 28(2):77-8. PubMed ID: 3373954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.